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Abstract 
Background 
Kidneys from donors after cardiac or circulatory death are exposed to extended periods of 
both warm ischemia and intra-arterial cooling before organ recovery. Marshall’s hypertonic 
citrate  (HOC)  and  Bretschneider’s  histidine-tryptophan-ketoglutarate  (HTK)  preservation 
solutions are cheap, low viscosity preservation solutions used clinically for organ flushing. 
The aim of the present  study  was  to  evaluate the effects  of these two solutions  both on 
parameters  used  in  clinical  practice  to  assess  organ  viability  prior  to  transplantation  and 
histological evidence of ischemic injury after reperfusion. Methods 
Rodent kidneys were exposed to post-mortem warm ischemia, extended intra-arterial cooling 
(IAC) (up to 2 h) with preservation solution and reperfusion with either Krebs-Hensleit or 
whole  blood  in  a  transplant  model.  Control  kidneys  were  either  reperfused  directly  after 
retrieval or stored in 0.9% saline. Biochemical, immunological and histological parameters 
were  assessed  using  glutathione-S-transferase  (GST)  enzymatic  assays,  polymerase  chain 
reaction and mitochondrial electron microscopy respectively. Vascular function was assessed 
by  supplementing  the  Krebs-Hensleit  perfusion  solution  with  phenylephrine  to  stimulate 
smooth  muscle  contraction  followed  by  acetylcholine  to  trigger  endothelial  dependent 
relaxation. 
Results 
When  compared  with  kidneys  reperfused  directly  post  mortem,  2  h  of  IAC  significantly 
reduced smooth muscle contractile function, endothelial function and upregulated vascular 
cellular  adhesion  molecule  type  1  (VCAM-1)  independent  of  the  preservation  solution. 
However, GST release, vascular resistance, weight gain and histological mitochondrial injury 
were dependent on the preservation solution used. 
Conclusions 
We  conclude  that  initial  machine  perfusion  viability  tests,  including  ischemic  vascular 
resistance and GST, are dependent on the perfusion solution used during  in situ cooling. 
HTK-perfused  kidneys  will  be  heavier,  have  higher  GST  readings  and  yet  reduced 
mitochondrial  ischemic  injury  when  compared  with  HOC-perfused  kidneys.  Clinicians 
should be aware of this when deciding which kidneys to transplant or discard. 
Background 
Donors after circulatory death (DCD) are increasingly being utilized by transplant centers in 
response to rising numbers of patients on organ waiting lists [1]. These donors are declared 
dead on the basis of cardiorespiratory parameters, rather than brain stem function, and there is 
therefore a period (10 to 40 minutes) of asystole and warm ischemia before organ retrieval. In 
the UK the number of DCDs increased over 70% between 2007 and 2011 [2]. 
The majority of these UK centers use controlled donors: patients declared dead in critical care 
units and rushed to the operating theatre for organ recovery using a standard aortic cannula to 
cool the abdominal organs [3]. Uncontrolled DCDs, where a patient is declared dead outside 
or shortly after reaching hospital, in the majority of centers, are cooled using a double balloon 
triple lumen (DBTL) catheter system capable of isolating the abdominal circulation via the 
femoral artery prior to organ retrieval. In both situations there is an extended period of warm 
ischemia (10 to 30 minutes) and a further extended period of intra-arterial cooling (IAC) (up 
to 2 h for uncontrolled) whilst the donor is transferred to theatre and/or the organs mobilized 
for topical cooling and recovery [4,5]. A critical feature of this period is that high flow IAC 
must be maintained to cool the renal parenchyma or the kidneys are ‘backwashed’ with warm 
blood from the thorax. As a result large quantities of preservation solution (up to 25 l) can be 
required in the uncontrolled situation [5]. Viscous solutions like University of Wisconsin (UW) solution have traditionally been too 
costly  for  this  purpose,  and  Marshall’s  hypertonic  citrate  (HOC)  [6]  or  Bretschneider’s 
histidine-tryptophan-ketoglutarate  (HTK)  [4,5]  have  been  preferred,  whilst  sanguineous 
perfusion  techniques  using  extracorporeal  membrane  oxygenation  requires  dedicated 
specialist teams and remains largely experimental [7,8]. 
Currently the risk that a kidney will never function (primary non-function) remains higher 
with DCDs than with either live or brain stem dead donors (circa 5% vs 1%) and [9,10] a 
number of centers, including our own, have a program of viability testing to identify severely 
damaged organs using hypothermic machine perfusion before implantation [9,11]. Perfusion 
criteria predicting early graft failure include high vascular resistance (pressure divided by 
flow  taking  into  account  the  weight  of  the  kidney;  pressure  flow  index  (PFI))  and  high 
perfusate glutathione-S-transferase levels (GST) [4,11,12]. 
In  previous  work  we  have  highlighted  the  differences  in  endothelial  preservation  using 
different perfusion solutions and have reported clinical data comparing kidneys perfused in 
HTK and HOC [13,14]. This set of experiments was designed to compare ‘whole organ’ 
kidney  perfusion  preservation  with  HTK  and  HOC,  with  particular  emphasis  on  warm 
ischemia  and  vascular  function,  in  order  to  understand  the  implications  of  our  previous 
clinical and experimental observations. 
Methods 
IAC and estimation of weight gain 
Male  Wistar  rats  (250  to  350  g)  were  killed  by  cranial  stunning  followed  by  cervical 
dislocation in accordance with Schedule 1 of the UK Animals (Scientific Procedures) Act 
1986. Immediate laparotomy was then performed and the left kidney reflected to expose the 
renal artery into which a 20 G cannula was secured. The kidney was then dissected free and 
weighed with cannula in place. IAC was initiated after a total of 30 minutes post-mortem 
warm ischemia with a 500-μl flush of streptokinase (144 IU Streptase®; Aventis Behring 
GmbH, Marburg, Germany) via the cannula [15]. Preservation solution (HTK or HOC) was 
then injected at a fixed flow rate (25 ml/h) having passed through a cooling circuit (6 to 
10°C).  Pressure  was  monitored  throughout  the  experiment  using  a  Power  Lab®  8e  (AD 
Instruments; New South Wales, Australia) transducer and the results recorded using Chart v.5 
(AD Instruments) software (Figure 1A). After 2 h the kidney was reweighed and transferred 
to the warm circuit for reperfusion (HTK and HOC, n = 8). Weight gain was calculated by 
subtracting the weight of the cannula from both readings and expressing the increase as a 
percentage. Negative control kidneys (n = 9) underwent the same protocol using normal saline 
as the preservation solution. Positive control kidneys (Control, n = 9) were flushed directly 
after cannulation with streptokinase and reperfused on the warm circuit; an ischemic period 
of  between  12  and  15  minutes.  In  further  experiments  kidneys  were  stored  in  the  same 
preservation  solution  (n = 6)  for  20  h  and  then  reperfused  with  whole  blood  prior  to 
mitochondrial analysis (see below). 
Figure 1 Representative recorded perfusion traces of a single kidney. (A) Pressure during 
intra-arterial cooling (IAC) with histidine-tryptophan-ketoglutarate (HTK) (blue); (B) after 
pulsatile reperfusion with Krebs Hensleit (red) reperfusion media. The arrow represents start 
of supplementation with phenylephrine and a rapid rise in mean pressures to around 200 mmHg. In (C) a 200 μl vehicle bolus is given with no change in mean perfusion pressure. 
However, in (D) 200 μl acetycholine stimulates endothelial dependent relaxation 
approximately 45 s later. Y-axis, mmHg; X-axis time (s) 
Reperfusion (‘warm’) circuit 
The warm circuit consisted of a rotor pump (Watson-Marlow; Falmouth, UK) capable of 
delivering pulsatile flow rates between 1 and 10 ml/min (Figure 1B-D). The perfusate (Krebs-
Hensleit solution) was made to previously published specifications and filter sterilized before 
use [16]. Perfusate was pumped from a warmed (37°C), oxygenated reservoir via a bubble 
trap and secondary warming coil into the kidney. Perfusate effluent was drained from round 
the  kidney  by  a  separate  circuit  and  either  stored  for  analysis  or  discarded.  Preliminary 
experiments  established  that  the  system  maintained  both  a  cannula  tip  and  perirenal 
temperature in the range of 37 ± 0.5°C. For the first 30 minutes of reperfusion the flow was 
adjusted  to  maintain  a  mean  arterial  pressure  of  approx.  90  mmHg.  At  30  minutes  post 
reperfusion the flow was fixed and phenylephrine (see below) added to the perfusate (Figure 
1B). 
Measurement of vascular resistance (VR) 
During both IAC and the second 30 minutes of reperfusion, mean arterial pressure was used 
as  a  surrogate  for  VR  (fixed  flow).  VR  during  the  first  30  minutes  of  reperfusion  was 
calculated using the following formula: 
mean arterial pressure mmHg
VR =
Flow ml/ min / Pre-perfusion kidney weight g
 
 
Assessment of vascular function 
Smooth muscle function was assessed as the maximal contractile response to the perfusate 
supplemented with the α-adrenergic agonist phenylephrine (10 μM) and reported as increase 
in VR (Figure 1B). At 45 minutes post reperfusion three boluses of the perfusate vehicle (200 
μl)  were  given  via  an  injection  port  in  the  circuit  to  ensure  there  was  no  agonist 
contamination (Figure 1C) and then four similar volume boluses of acetylcholine (2 μM, 20 
μM, 200 μM, 2,000 μM) injected at 3-minute intervals (Figure 1D) to stimulate endothelial 
dependent  relaxation  [16].  A  final  bolus  of  papaverine  (10  mM)  at  1-h  post  reperfusion 
elicited endothelial independent relaxation. This is reported as a percentage of the initial 
phenylephrine  induced  contraction  and  endothelial  independent  relaxation  calculated,  for 
each acetylcholine bolus, as a percentage of the papaverine relaxation. 
GST activity 
Samples of perfusate effluent were taken each hour during IAC and every 15 minutes during 
reperfusion and snap frozen for GST enzyme activity analysis, which is a marker of renal 
tubular cell damage. This was performed using a previously published spectrophotometric 
method on an automated analyzer [17]. Real-time polymerase chain reaction (PCR) 
After the end of reperfusion (1 h) a 5 × 3 mm section was removed from the upper pole of 
each  kidney  and  stored  in  RNAlater®  (Ambion,  Texas,  USA).  RNA  extraction  was 
performed with an initial homogenization in 1 ml of phenol:guanidine thiocyanate solution 
(RNAzol  B®;  IsoTex  Diagnostics,  Texas,  USA)  combined  with  chloroform.  Subsequent 
isopropanol and ethanol washes produced a nucleic acid/protein pellet  which was  further 
purified  using  phenol:chloroform  and  centrifuged  with  Phase  Lock  Gels®  (VWR 
International,  Leicester,  UK).  Total  RNA  content  and  integrity  were  assessed  using 
spectrophotometry (absorbance 260 nm) and gel electrophoresis before cDNA synthesis with 
an MMLV reverse transcriptase (Bioline, London, UK). At this stage the positive control 
kidney cDNA was  pooled and aliquots used in subsequent  amplifications  as  a consistent 
reference. Validated exon-spanning TaqMan® primers (B-actin Rn 00667869; intercellular 
adhesion molecule type 1 (ICAM-1) Rn 00564227; vascular cellular adhesion molecule type 
1  (VCAM-1)  Rn  00563627;  RANTES  (for  ‘regulated  upon  activation,  normal  T  cell 
expressed and secreted’) Rn 00579590 ml; Applied Biosystems, CA, USA) were used during 
amplification on a real-time quantitative thermal cycler (RG-3000; Corbett Research, Sydney, 
Australia). PCR products were quantified using the 2
-∆∆CT method [18], normalizing to B 
actin, and the results for each experimental replicate expressed as fold changes relative to 
control. 
Whole blood ‘buddy’ reperfusion 
After IAC a number of kidneys were recovered for reperfusion using a ‘recipient’ animal 
after 20 h cold ischemia. Each kidney recovered was reperfused by a separate, male Wistar 
rat  of  similar  size  to  the  donor.  In  brief,  the  recipient  animal  was  anaesthetized  by  gas 
induction  (isoflurane)  and  maintained  with  intraperitoneal  and  intravenous  boluses  of 
Hypnorm® (Janssen, Oxford, UK; fentanyl citrate 0.15 mg/ml; fluanisone 10 mg/ml) and 
midazolam. The left femoral vessels were exposed, controlled (bulldog clips) and cannulated 
with heparin coated, PTFE cannulae (Instech Laboratories, Plymouth, USA; 3 F in artery, 3.5 
F in vein). Cannula patency was maintained by heparinization of the recipient (single bolus of 
100 IU). The renal vessels were then secured using surgical ties and the vessel clips released 
to initiate reperfusion. After 4 h, reperfusion was terminated by dividing the renal vessels at 
the hilum and euthanizing the recipient. The recipient’s native left kidney was recovered 
immediately post mortem for use as a negative control (minimal ischemic injury). 
Mitochondrial injury 
Renal  tissue  was  prepared  for  electron  microscopy  using  a  previously  described  fixation 
method [14]. For each kidney sample, 40 high powered fields were selected at random and 
the mitochondria in each field were assigned an injury grade by a single observer blinded to 
the identity of the sample (MH). The Trump scale for mitochondrial injury was used to assess 
viability [19]. This identifies seven grades of renal tubular injury, on a linear scale, ranging 
between potentially viable tissue (1 to 4) and non-viable tissue (5 to 7) (Figure 2). 
Figure 2 Trump grades 2 to 4 of mitochondrial injury. Well-preserved mitochondria, 
showing elongated, orthodox conformation (injury grade 2). Mitochondria showing injury 
with condensation of their inner compartments, increased density of the matrices and 
expansion of intracristal spaces (grade 3). Mitochondria showing maximal, reversible injury with markedly condensed matrices and markedly expanded intracristal spaces. The inner 
compartments are expanded and those with flocculent densities may have irreversible injury 
(injury grade 4) 
Statistical analysis 
Unless otherwise specified parametric data is presented as mean ± standard error of the mean 
(SEM) and compared using analysis of variance (ANOVA) with the Bonferroni post hoc test. 
Non-parametric data was identified using the Kolmogorov-Smirnov test, and presented as the 
median and range. Between-group comparisons were made with the Kruskal-Wallis test or 
Mann-Whitney U test depending on the number of groups. Error bars represent the standard 
error of the mean  and range for normally distributed data  and skewed  data respectively. 
Statistical significance was interpreted as a P value <0.05 for the two-sided hypothesis. All 
calculations  and  graphical  representations  were  performed  using  Prism  V.4  (Graphpad 
Software Inc.; San Diego, California, USA). 
Results 
Vascular resistance during intra-arterial cooling 
There were no significant differences in the kidney weights between the experimental groups 
(1.29 ± 0.01 g, range 1.0 to 1.45) (Figure 3A). All the kidneys had a similar perfusion profile 
over the first minute of IAC, reaching a pressure of around 50 mmHg within the first minute. 
After this time point VR varied dependent on the preservation solution used, rising with HTK 
(maximum 76.7 mmHg at 4 minutes) or normal saline (max. 68 mmHg at 21 minutes) and 
dropping with Marshall’s HOC (mean plateau 29 mmHg). 
Figure 3 (A) Intra-arterial cooling (IAC) perfusion profiles with histidine-tryptophan-
ketoglutarate (HTK) (n = 8), Marshall’s hypertonic citrate (HOC) (n = 8) and normal 
saline (negative control n = 9). Lines and bars represent mean ± SEM. Data abbreviated at 1 
h (analysis of variance (ANOVA) with Bonferroni P <0.001). (B) Weight gain, same data 
sets, after IAC; mean ± SEM (t test P <0.01) 
Weight gain during intra-arterial cooling 
All  the kidneys  became edematous  during  IAC, noticeable macroscopically, although the 
magnitude of this  gain  was  related to  the preservation solution: HOC 33 ± 4% and HTK 
58 ± 3% having statistically (P <0.01, ANOVA with Bonferroni) less weight gain than with 
negative control 82 ± 4% (Figure 3B). 
Vascular function after reperfusion 
The VR during IAC was reflected in the VR at reperfusion with the negative control kidneys 
not  only  having  the  highest  values  at  all  time  points  (P  <0.001),  but  also  showing  no 
indication of improving over time (Figure 4A). In contrast both HTK and HOC had VRs 
comparable to positive control, which improved within the short period of reperfusion and 
was accompanied by the washout of erythrocytes before the addition of phenylephrine. The 
response to this agonist was blunted in the experimental groups (Figure 5A) and endothelial 
independent  relaxation  greater  when  compared  with  the  positive  controls  (Figure  5B). Endothelial dependent relaxation was reduced in all the experimental groups (P <0.05) and 
lowest in the negative control group, although there were no significant differences between 
the preservation solutions (Figure 4B). 
Figure 4 Reperfusion variables (I). (A) Vascular resistance during reperfusion. (B) 
Endothelial dependent relaxation as a percentage of phenylephrine contraction. (C) 
Glutathione-S-transferase (GST) release during intra-arterial cooling (IAC) and reperfusion. 
Lines and bars represent mean and SEM, P values, analysis of variance (ANOVA) with 
Bonferroni. Histidine-tryptophan-ketoglutarate (HTK) and hypertonic citrate (HOC) (n = 8), 
negative control (n = 9) NS, non-significant 
Figure 5 Reperfusion variables (II). (A) Contractile response to phenylephrine. Bars 
represent mean ± SEM, P values, analysis of variance (ANOVA) with Bonferroni. (B) 
Endothelial independent relaxation in response to papaverine bolus. Percentage of 
phenylephrine contraction. Bars represent mean ± SEM, P values, ANOVA with Bonferroni. 
(C) Immune activation (mRNA) as measured by real-time polymerase chain reaction (PCR) 
normalized to B actin and expressed as fold change over positive control. Bars represent 
median and range. Histidine-tryptophan-ketoglutarate (HTK) and hypertonic citrate (HOC) 
(n = 8), negative control (n = 9). NS, non-significant 
GST, RANTES and adhesion molecules 
The GST values highlighted a major difference in renal tubular cell response to ischemia 
reperfusion  injury  (IRI)  dependent  on  the  preservation  solution.  The  values  seen  during 
ischemia were higher in HTK-perfused kidneys than Marshall’s, but during reperfusion this 
ratio  was  reversed  with  almost  a  threefold  difference  in  GST  perfusate  readings  at  15 
minutes.  Of  the  adhesion  molecules,  ICAM-1,  was  significantly  overexpressed  when 
compared with Marshall’s, but not HTK, and VCAM-1 was the most globally upregulated of 
the three tested (8-fold to 57-fold). See Figures 4C and 5C. 
Mitochondrial injury 
There  were  significant  differences  between  kidneys  perfused  and  stored  in  the  two 
preservation  solutions  when  compared  with  kidneys  recovered  post  mortem  (Figure  6). 
Kidneys  preserved  in  HTK  had  a  median  injury  grade  of  3  (interquartile  range  2  to  4) 
whereas those preserved in Marshall’s had a grade of 4 (interquartile range 4 to 5) and this 
difference was statistically significant (P <0.0001). 
Figure 6 Mitochondrial injury. Electron microscopic comparison by blinded observer of 
mitochondria according to Trump scale of injury. Histidine-tryptophan-ketoglutarate (HTK), 
Marshall’s hypertonic citrate (HOC) and control (n = 6). Lines and bars represent median and 
range with interquartile box. Data significant at P <0.0001, Mann-Whitney U test 
Discussion 
The vascular system is more than just a conduit for oxygenated blood to peripheral tissues. 
The interaction between vascular smooth muscle cells, endothelium and luminal contents 
regulates vascular tone and barrier function by cells responding to and producing vasoactive 
mediators, adhesion molecules and chemokines. In these experiments we have shown that warm ischemia and intra-arterial cooling have variable effects on organ vascular function and 
mitochondrial integrity some of which are dependent and some of which are independent of 
the preservation solution. 
The vascular resistance during donor perfusion was strikingly different between HTK and 
HOC  when  compared  with  normal  saline.  In  further  experiments,  not  reported  here,  we 
changed  the  osmolarity  of  the  three  solutions  with  mannitol  and  showed  that  this 
manipulation  was  responsible  for  the  majority  of  the  difference  in  perfusion  pressures 
(unpublished  data).  This  was  also  mirrored  in  the  weight  gain:  edema  being  directly 
correlated with osmolarity and flow. In a porcine study using controlled pressure perfusion, 
weight gain with HOC was 50%, suggesting that the overall volume and flow in this study 
were not excessive [20]. 
However, the differences  in  endothelial dependent  relaxation between  HTK and HOC in 
response to acetylcholine were less striking than our previous experiments in rodent aorta had 
suggested: this may reflect the shorter period of ischemia or a true tissue specific difference. 
We did try and record acetylcholine responses after long periods of cold storage, but the 
results were confounded by very low response rates in all preservation media. 
Endothelial  independent  relaxation was  numerically  greater than the positive control  (see 
Figure  5C),  but  this  probably  represents  a  higher  level  of  basal  vascular  tone  pre-
phenylephrine  (these  figures  exceed  a  100%  of  the  induced  vasoconstriction)  rather  than 
actual  enhanced  responsiveness.  Markers  of  immune  activation  (Figure  5C)  were  also 
upregulated relatively independently of preservation solution and quantitatively were greatest 
for the vascular endothelial  adhesion  molecule VCAM-1 which can be overexpressed on 
renal tubular as well as vascular endothelial cells [21,22]. 
Choice of perfusion solution did have a significant bearing on the measured release of the 
GST viability enzyme (Figure 4C); with a threefold increase in the amount of tubular cell 
death in the HOC perfusion group when compared with HTK, negative and positive controls. 
We do not believe that saline provides better protection for the renal tubular cell than either 
HTK or HOC; a more plausible explanation would be that lack of tissue perfusion prevented 
a complete extrusion of the released GST from the negative control treated kidneys in the 
short  time  frame.  The  contrast  between  GST  release  during  ischemia  and  reperfusion  of 
kidneys perfused with HTK and HOC suggests a ‘paradox’ type injury. We speculate that the 
greater pH buffering capability of HTK makes the kidney confusingly susceptible to cellular 
damage during ischemia [23] but relatively protected during reperfusion. Conversely, with 
HOC treated kidneys, the greater acidosis is initially protective, [24] but reperfusion and 
resumption of aerobic metabolism triggers proteolytic enzyme activity and exaggerated cell 
death  [25]. Hence,  a minor increase in  tubular  damage seen with  HTK during  ischemia, 
precedes a much larger reperfusion ‘hit’ with HOC. This would concur with other studies 
documenting the relative lack of protection conferred by HOC on reperfusion injury after 
warm ischemic injury [14,26,27]. Of course, most DCD kidneys are transplanted after ex vivo 
preservation with either UW static storage solution or after a period of hypothermic perfusion 
preservation. It is unclear whether this period effectively abrogates the differences between 
HTK and HOC or whether there are specific ‘interactions’ between different combinations of 
solutions, which are either beneficial or harmful. In common with other units we would not 
advocate storage of DCD kidneys in either HTK or HOC [28]. Conclusions 
The  most  relevant  and  immediate  clinical  deductions  from  these  experiments  are  the 
implications for viability testing of kidneys. All other factors being equal, centers using HTK 
for IAC could reasonably expect the retrieved kidneys to be larger, have a higher initial 
resistance and ischemic GST values than kidneys exposed to warm ischemia and HOC for a 
similar period of time. Indeed, in our own clinical transplant program we have noticed that 
this is the case and it was these observations that stimulated this research (see introduction 
[13]). The mitochondrial injury studies have clear viability implications for perfusing and 
storing kidneys with HOC and we have stopped perfusing or storing DCD kidneys in HOC. 
Further experimental work is required to examine the interactions between HTK and HOC 
with ex vivo perfusion preservation and the UW type preservation solutions. 
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